GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
25,100
+100 (0.40%)
Apr 29, 2026, 2:50 PM KST
-30.66%
Market Cap 1.10T
Revenue (ttm) 81.53B
Net Income (ttm) -11.34B
Shares Out 43.95M
EPS (ttm) -275.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 271,781
Average Volume 372,055
Open 26,850
Previous Close 25,000
Day's Range 24,750 - 27,100
52-Week Range 22,150 - 72,700
Beta 1.46
RSI 36.61
Earnings Date n/a

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Industrial - Machinery
Sector Industrials
Founded 1998
Employees 182
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2025, GemVax&KAEL's revenue was 81.53 billion, an increase of 30.05% compared to the previous year's 62.69 billion. Losses were -11.34 billion, -87.00% less than in 2024.

Financial Statements

News

There is no news available yet.